Objectives : Weinvestigatedthesynergisticeffectsofbeevenom(BV)andnaturalkiller (NK) cellsonB16F10melanomacellapoptosismediatedbyIL-4. Methods : WeperformedacellviabilityassaytodeterminewhetherBVcanenhancetheinhibitory effectofNK-92MIcellsonthegrowthofB16F10melanomacells,andwesternblotanalysisto detectchangesintheexpressionofIL-4,IL-4Rα,andotherapoptosis-relatedproteins.EMSA wasperformedtoobservetheactivityofSTAT6.ToconfirmthattheinhibitoryeffectofBV andNKcellswasmediatedbyIL-4,theabovetestswererepeatedafterIL-4silencingby siRNA(50nM). Results : B16F10melanomacellsco-culturedwithNK-92MIcellsandsimultaneouslytreatedby BV(5μg/ml)showedahigherdegreeofproliferationinhibitionthanwhentreatedbyBV(5 μg/ml)aloneorco-culturedwithNK-92MIcellsalone.ExpressionofIL-4,IL-4Rα,andthat ofotherpro-apoptoticproteinswasalsoenhancedafterco-culturewithNK-92MIcellsand simultaneoustreatmentwithBV(5μg/ml).Furthermore,theexpressionofanti-apoptoticbcl2decreased,andtheactivityofSTAT6,aswellastheexpressionofSTAT6andp-STAT6 wereenhanced.IL-4silencingsiRNA(50nM)inB16F10cells,theeffectsofBVtreatmentand NK-92MIco-culturewerereversed.
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Ⅰ. Introduction
Malignant melanoma is a malignancy of pigment producing cells (melanocytes), which are located primarily in the skin 1) . The incidence of melanoma is increasing worldwide, and the prognosis for patients with high-risk or advanced metastatic melanoma remains poor despite advances in the field 2) .
Immunological cytokines, such as interleukin-4
(IL-4), play important roles in the regulation of immune cell function. IL-4 was originally described as a B-cell growth factor, but is since known to activate and differentiate other immune cells as well 3) . IL-4, which exerts its effects by interacting with cell surface receptors, has been used in immunotherapies to enhance the immune response against tumors in both mice and humans 4, 5) .
IL-4 induces apoptosis of 549 lung adenocarcinoma cells through two pathways: direct activation and mitochondrial pathway 6) . .
Bee venom (BV) was used in ancient China for apitherapy and it is mentioned in the Huangdi Neijing. It has been used in oriental medicine for many years to treat inflammatory diseases 8) , and in Korean medicine in pharmacopuncture to treat back pain, rheumatism, and many skin diseases due to its antibacterial, antiviral, and anti-inflammatory effects 9, 10) . BV consists of a complex mixture of proteins, peptides, and low molecular weight components. BV increases pro-apoptotic proteins by increasing the expression of death receptor (DR) in the cell surface and simultaneously inhibiting the activity of anti-apoptosis factors [11] [12] [13] [14] . Several experimental studies have demonstrated that BV and/or melittin have anti-cancer effects 9, 10, 15) . Additionally, it has been reported that BV enhances the cytotoxic effects of NK cells on human lung cancer and acts synergistically with NK cells to inhibit cancer cell growth 16, 17) . 
2.Cellculture

3.Cellviabilityassay
To determine cell numbers, B16F10 cells alone or 
5.Electrophoreticmobilityshiftassay (EMSA)
The DNA binding activity of STAT6 was deter- 
7.Dataanalysis
The data were analyzed using the GraphPad Ⅲ. Results
1.EffectsofBVandNK-92MIcells onthecellviabilityofB16F10cells
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3.EffectsofBVonSTAT6activation inB16F10cells
It is reported that IL-4 induces STAT6 activation, and that snake venom toxin also influences STATs. (Fig. 3) . The same conditions that resulted in increased DNA binding activity of STAT6 also led to enhanced phosphorylation of nuclear STAT6 in B16F10 cells (Fig. 3 ). (Fig. 4) .
4.siRNA-mediated IL-4 silencing reversestheinhibitoryeffectsof BVandNK-92MIcellsonB16F10 cellgrowth
5.siRNA-mediated IL-4 silencing reversestheeffectsofBVand NK-92MIcellsonapoptoticand cytotoxicregulatoryproteinexpressioninB16F10cells
To further ascertain whether the synergistic ef- TheAcupunctureVol.34No.1February2017 B16F10 melanoma cells were transfected with an IL-4 siRNA (50 nM) for 24 h, and the cells were then treated with BV (5 μg/ml) for another 24 h. Expression of IL-4, IL-4Rα, Bax, bcl-2, caspase-3, caspase-9, cleaved caspase-3, and cleaved caspase-9 was then determined. β-actin protein was used an internal control. Each blot is representative of three experiments. (Fig. 6 ).
Ⅳ. Discussion
Apoptosis is induced mainly by the intrinsic mitochondria-mediated pathway or the extrinsic DRmediated pathway and their interplay 8) . DRs generally bind to their specific ligands or antibodies, which induce receptor trimerization and clustering through the characteristic death domain (DD), recruitment of intracellular adaptor proteins and procaspase-8, and DR inducing signal complex (DISC) formation [19] [20] [21] [22] . Once the DISC has been formed, an intracellular cascade of caspase activation is initiated: initiator caspases (caspase-8, -9 and -10) can active effector caspases, such as caspase-3 and -6, initiating programmed cell death 23) . In the case of the intrinsic mitochondrial-mediated pathway, Bax activation and its subsequent translocation to the mitochondria, accompanied by a decrease in Bcl-xL, lead to cytochrome c release, which activates caspase-3
and caspase-9, leading to apoptosis 6, 23) . Additionally, . STAT6 is synergistically activated by BV treatment and NK-92MI cells (Fig. 3) , further confirming the synergistic action of BV and NK-92MI cells in the regulation of IL-4-mediated biological responses. This study shows that such an action can inhibit proliferation and differentiation of B16F10 melanoma cells through IL-4-mediated apoptosis. Indeed, siRNA-mediated IL-4 silencing in B16F10 followed by BV treatment reversed the effects and cell viability increased (Fig. 4) .
Similarly, expression of IL-4, IL-4Rα , and other pro-apoptotic proteins was decreased, and that of anti-apoptotic bcl-2 increased upon siRNA-mediated IL-4 silencing in B16F10 cells (Fig. 5) . Moreover, STAT6 activation was reversed, as assessed by EMSA and western blot analysis. (Fig. 6 
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